Development of warm autoimmune hemolytic anemia after initiation of Ruxolitinib in a patient with STAT1 gain-of-function mutation

被引:1
|
作者
Hartono, Stella [1 ]
Agharahimi, Anahita [2 ]
Tauk, Silpa [3 ]
Bosticardo, Marita [2 ]
Mangat, Mona [4 ]
Pfister, Justina [5 ]
Notarangelo, Luigi [6 ]
Leiding, Jennifer [7 ]
Freeman, Alexandra [6 ]
机构
[1] NIAID, Bethesda, MD USA
[2] NIH, Bethesda, MD USA
[3] Univ S Florida, Tampa, FL USA
[4] Bay Area Allergy & Asthma, Allergy Immunol, Berkeley, CA USA
[5] NIAID, Primary Immunodeficiency Clin, Bethesda, MD USA
[6] NIAID, NIH, Bethesda, MD USA
[7] Johns Hopkins South Florida, St Petersburg, FL USA
关键词
STAT1; gain-of-function; Ruxolitinib; Autoimmune hemolytic anemia; Sirolimus;
D O I
10.1016/j.clim.2023.109413
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
66
引用
收藏
页码:29 / 29
页数:1
相关论文
共 49 条
  • [1] Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation
    Kunihiko Moriya
    Tasuku Suzuki
    Nao Uchida
    Tomohiro Nakano
    Saori Katayama
    Masahiro Irie
    Takeshi Rikiishi
    Hidetaka Niizuma
    Satoshi Okada
    Kohsuke Imai
    Yoji Sasahara
    Shigeo Kure
    International Journal of Hematology, 2020, 112 : 258 - 262
  • [2] Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation
    Moriya, Kunihiko
    Suzuki, Tasuku
    Uchida, Nao
    Nakano, Tomohiro
    Katayama, Saori
    Irie, Masahiro
    Rikiishi, Takeshi
    Niizuma, Hidetaka
    Okada, Satoshi
    Imai, Kohsuke
    Sasahara, Yoji
    Kure, Shigeo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (02) : 258 - 262
  • [3] Orf Infection in a Patient with Stat1 Gain-of-Function
    Kilic, Sara Sebnem
    Puel, Anne
    Casanova, Jean-Laurent
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (01) : 80 - 83
  • [4] Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation
    Markéta Bloomfield
    Veronika Kanderová
    Zuzana Paračková
    Petra Vrabcová
    Michael Svatoň
    Eva Froňková
    Martina Fejtková
    Radana Zachová
    Michal Rataj
    Irena Zentsová
    Tomáš Milota
    Adam Klocperk
    Tomáš Kalina
    Anna Šedivá
    Journal of Clinical Immunology, 2018, 38 : 589 - 601
  • [5] Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation
    Bloomfield, Marketa
    Kanderova, Veronika
    Parackova, Zuzana
    Vrabcova, Petra
    Svaton, Michael
    Fronkova, Eva
    Fejtkova, Martina
    Zachova, Radana
    Rataj, Michal
    Zentsova, Irena
    Milota, Tomas
    Klocperk, Adam
    Kalina, Tomas
    Sediva, Anna
    JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (05) : 589 - 601
  • [6] JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia
    Rosenberg, Jacob M.
    Peters, Joshua M.
    Hughes, Travis
    Lareau, Caleb A.
    Ludwig, Leif S.
    Massoth, Lucas R.
    Austin-Tse, Christina
    Rehm, Heidi L.
    Bryson, Bryan
    Chen, Yi-Bin
    Regev, Aviv
    Shalek, Alex K.
    Fortune, Sarah M.
    Sykes, David B.
    MED, 2022, 3 (01): : 42 - +
  • [7] Gain-of-Function STAT1 Mutation With Familial Lymphadenopathy and Hodgkin Lymphoma
    Henrickson, Sarah E.
    Dolan, Joseph G.
    Forbes, Lisa R.
    Vargas-Hernandez, Alexander
    Nishimura, Shiho
    Okada, Satoshi
    Kersun, Leslie S.
    Brodeur, Garrett M.
    Heimall, Jennifer R.
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [8] Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation
    Basak Kayaoglu
    Nurhan Kasap
    Naz Surucu Yilmaz
    Louis Marie Charbonnier
    Busranur Geckin
    Arzu Akcay
    Sevgi Bilgic Eltan
    Gulyuz Ozturk
    Ahmet Ozen
    Elif Karakoc-Aydiner
    Talal A. Chatila
    Mayda Gursel
    Safa Baris
    Journal of Clinical Immunology, 2021, 41 : 769 - 779
  • [9] Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation
    Kayaoglu, Basak
    Kasap, Nurhan
    Yilmaz, Naz Surucu
    Charbonnier, Louis Marie
    Geckin, Busranur
    Akcay, Arzu
    Eltan, Sevgi Bilgic
    Ozturk, Gulyuz
    Ozen, Ahmet
    Karakoc-Aydiner, Elif
    Chatila, Talal A.
    Gursel, Mayda
    Baris, Safa
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (04) : 769 - 779
  • [10] Hematopoietic Stem Cell Transplantation in Patients with Heterozygous STAT1 Gain-of-Function Mutation
    Kiykim, Ayca
    Charbonnier, Louis Marie
    Akcay, Arzu
    Karakoc-Aydiner, Elif
    Ozen, Ahmet
    Ozturk, Gulyuz
    Chatila, Talal A.
    Baris, Safa
    JOURNAL OF CLINICAL IMMUNOLOGY, 2019, 39 (01) : 37 - 44